ZBH FINANCIAL STATEMENTS

Zimmer Biomet Holdings Inc — balance sheet, income statement and cash flow trends

ZBHZimmer Biomet Holdings Inc

🇺🇸 USA · US · Healthcare · Medical Devices

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue8.4 B $+9.2%

Gross Profit5.9 B $+7.7%

Operating Income1.3 B $+0.0%

EBITDA2.2 B $-3.9%

Net Income761.3 M $-16.7%

Peer Comparison· Medical Devices

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ZBH	9.2%	70.0%	26.2%	9.1%
PHIA	-1.9%	45.2%	15.4%	5.5%
SHL	-0.3%	38.0%	19.1%	9.1%
COH	2.0%	73.0%	24.0%	14.6%
4DX	-26.0%	-396.6%	-818.8%	-3,684.6%
Industry median	7.4%	58.9%	5.2%	-5.7%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ZBH	9.2%	70.0%	26.2%	9.1%
STE	8.7%	44.2%	30.8%	13.2%
PEN	17.3%	67.4%	15.2%	11.8%
PODD	31.9%	71.0%	19.8%	10.4%
GMED	23.5%	67.9%	28.4%	18.9%
DXCM	16.1%	61.8%	30.6%	19.3%
Industry median	7.4%	58.9%	5.2%	-5.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity12.7 B $56%
Current Liabilities2.9 B $13%
Long-term Liabilities7.2 B $32%

Key Figures

YoY change

Total Assets22.7 B $+2.4%

Total Liabilities10 B $+2.7%

Total Equity12.7 B $+2.2%

Cash & ST Investments424.2 M $-69.4%

Total Debt7.5 B $+4.1%

Net Debt7 B $+21.7%

Peer Comparison· Medical Devices

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ZBH	1.73	59.0%	3.19	55.8%
PHIA	1.32	71.1%	2.03	41.8%
SHL	1.10	84.1%	3.04	40.6%
COH	2.46	22.1%	0.42	69.4%
4DX	6.57	-22.6%	0.71	-20.4%
Industry median	3.28	44.7%	0.82	49.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ZBH	1.73	59.0%	3.19	55.8%
STE	2.09	29.1%	0.90	66.9%
PEN	6.02	14.7%	-0.11	77.6%
PODD	2.49	72.8%	0.81	43.6%
GMED	4.56	2.4%	-0.58	87.0%
DXCM	1.95	46.8%	-0.70	44.6%
Industry median	3.28	44.7%	0.82	49.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow1.7 B $+1.2%

Capital Expenditures394.9 M $+29.3%

Free Cash Flow1.8 B $+36.1%

Dividends Paid-189.4 M $-197.4%

Peer Comparison· Medical Devices

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ZBH	19.9%	21.8%	4.7%	219.8%
PHIA	13.0%	10.8%	2.2%	236.4%
SHL	12.2%	8.7%	3.5%	134.0%
COH	11.2%	8.5%	2.7%	76.6%
4DX	-761.6%	-530.7%	3.7%	20.7%
Industry median	7.2%	1.5%	4.1%	76.6%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ZBH	19.9%	21.8%	4.7%	219.8%
STE	22.6%	16.4%	6.2%	171.4%
PEN	19.0%	14.6%	4.4%	161.7%
PODD	21.3%	14.2%	7.1%	204.5%
GMED	25.1%	19.4%	5.7%	132.7%
DXCM	37.0%	29.7%	7.3%	191.6%
Industry median	7.2%	1.5%	4.1%	76.6%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ZBH

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.